Cargando…
The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
BACKGROUND: There are a few studies about paradoxical bronchodilator response (BDR), which means a decrease in forced expiratory volume in 1 second (FEV(1)) or forced vital capacity (FVC) after short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease (COPD)....
Autores principales: | Shin, Hong-Joon, Kim, Tae-Ok, Kim, Yu-Il, Kim, Sang-Hoon, Kim, Hyun Kuk, Kim, Yong-Hyun, Byun, Min Kwang, Jung, Ki-Suck, Yoo, Kwang-Ha, Lee, Jae Seung, Lim, Sung-Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947541/ https://www.ncbi.nlm.nih.gov/pubmed/33717524 http://dx.doi.org/10.21037/jtd-20-985 |
Ejemplares similares
-
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
por: Kang, Jieun, et al.
Publicado: (2017) -
Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
por: Kim, Junghyun, et al.
Publicado: (2017) -
Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity
por: Choi, Joon Young, et al.
Publicado: (2023) -
Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019) -
Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)